40Research opportunities
44Commercial whitespaces
39Ecosystem support needs
Key: Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based
Opportunity Production platform Value chain segment Technology sector End product focus Relevant actor
Affordable animal-free omega-3 ingredients for alternative seafood and other alternative protein applications

In order to appeal to health-conscious consumers, alternative seafood products should contain similar omega-3 fatty acids, especially DHA and EPA, content to conventional seafood. Animal-free omega-3 ingredients can be expensive…

Fermentation icon Fermentation Plant-based icon Plant-Based Investment Production R&D Raw Materials, Ingredients, & Inputs Bioprocess design Crop development Host strain development Ingredient optimization Target molecule selection Seafood Industry Investors Startups
Preventing oxidation of omega-3 fatty acids before and after addition to alternative seafood products

Deeper fundamental knowledge of the causes and prevention of oxidation of omega-3 fatty acids before, during, and after addition to alternative seafood products is needed to improve their nutritional and…

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based End Products Investment Production R&D Raw Materials, Ingredients, & Inputs Bioprocess design Crop development End product formulation & manufacturing Host strain development Ingredient optimization Target molecule selection Seafood Academics Industry Investors Startups
Coordination among investors with alternative protein industry-specific expertise

Investors specializing in alternative proteins should be leveraged to educate the broader investment community through coalitions, syndicated deals, and co-investments with industry-agnostic investors, and spearhead efforts to facilitate later-stage funding…

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Species-agnostic GFI Investors Startups
Guaranteed offtake contracts for products and ingredients

Guaranteed offtake agreements, where buyers commit to purchase a volume of product, can help secure loans for infrastructure and other high-cost projects.

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based End Products Investment Production End product formulation & manufacturing Species-agnostic Industry Policymakers
Platform for facilitating matchmaking between funders and funding-seekers

It can be challenging and time-intensive for startups and researchers to find funders that are interested in their technology area, technological maturity level, fundraising stage, location, type of funding sought,…

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Species-agnostic GFI Investors
Infrastructure loan fund

The success of early-days products has demonstrated strong consumer interest, but investment is needed to enable alternative protein supply chain companies to build out the infrastructure needed to capitalize on…

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Production Species-agnostic Industry Investors
Infrastructure and equipment leasing fund

Infrastructure leasing for production and processing facilities as well as capital equipment would enable alternative protein companies to rapidly expand capacity without large upfront capital investments. Having leasing funds and…

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Production Raw Materials, Ingredients, & Inputs Species-agnostic Industry Investors
Investor conference for LPs, funds of funds, corporate VCs, family offices, and money managers

Events targeted at promoting opportunities in alternative protein investment via specialized funds could facilitate and diversify investment.

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Species-agnostic GFI Investors
Options for factoring financing for alternative proteins

Increased access to factoring financing instruments would help alternative protein companies improve their cash conversion cycle.

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Species-agnostic Investors
Expanding alternative protein accelerator programs

More alternative protein capacity—different geographies, expertise, and programming—is needed in the incubator and accelerator landscape to de-risk venture capital investment.

Cultivated icon Cultivated Fermentation icon Fermentation Plant-based icon Plant-Based Investment Species-agnostic Industry Investors

Get involved

If you’d like to fund a research project, work on any of these solutions, share information about related efforts that are already underway, or elevate new ideas for advancing the alternative protein industry, we’d love to hear from you!

Swinging lit lightbulb graphic representing gfi's innovation priorities

Explore key innovation priorities

Review commercial whitespaces, research gaps, technological needs, and investment priorities at each stage of the alternative protein value chain.

How we built this

Advancing solutions for alternative proteins executive summary icon

Executive summary

Get an overview of GFI’s Solutions initiative and a summary of key resources.

Advancing solutions for alternative proteins full report icon

Full report

Delve into the full report on the motivation, methodology, rationale, and key findings and recommendations of the Solutions initiative.

Advancing solutions for alternative proteins future wheels analysis icon

Futures wheels analysis

Explore our framework for uncovering second-order or third-order consequences and implications of hypothetical future scenarios to support better decision-making in the present.

Advancing solutions for alternative proteins future-proofing report icon

Future-proofing

Discover key findings from GFI’s premortem analysis of potential threats to the widespread adoption of alternative proteins, including strategies to avoid or mitigate the most pressing risks.